Improving Global Outcomes (KDIGO) group has updated chronic kidney disease treatment guidelines to help slow disease progression in adults. A JAMA article published Wednesday summarized the revised ...

Revelation Biosciences, Inc. (NASDAQ: REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company focused ...

Healthinote is a smartphone-based toolkit designed to boost patient engagement by providing personalised, trustworthy, and ...

North East and North Cumbria NHS has begun a year-long rollout of the Healthinote digital health platform to support patients ...

New research identifies diabetes as an independent predictor of major adverse cardiovascular events in patients with both ...

A new study published in the journal of Risk Management and Healthcare Policy showed that the frequency of magnesium ...

This study examined the correlation between atopic dermatitis and the risk for chronic kidney disease using data from a Taiwanese health database.

AstraZeneca announced that baxdrostat, a selective aldosterone synthase inhibitor, met its primary and all secondary endpoints in the BaxHTN Phase III trial, effectively lowering blood pressure ...

Emmerdale fans were quick to share their belief that a villager is helping new villain Dr Crowley blackmail Joe Tate and ...

Baxdrostat meets primary and all secondary endpoints in BaxHTN phase III trial in patients with uncontrolled or treatment resistant hypertension: Cambridge, UK Wednesday, July 16, ...

HDE Surveillance Registry Data Captures Key Metrics for Future Analysis of QUELIMMUNE Performance DENVER, July 16, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a ...

In a significant push to address one of the Philippines’ most pressing but underrecognized public health issues, the German-Philippine Chamber of Commerce and Industry (GPCCI), the German Embassy ...